{"id":"W2075096471","doi":"10.1007/s00280-011-1657-1","title":"A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Capecitabine; Gemcitabine; Medicine; Internal medicine; Gallbladder cancer; Gallbladder; Gastroenterology; Regimen; Cancer; Oncology; Biliary tract cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000251202,0.0003856693,0.001131381,0.0002451494,0.0001248826,0.000008410505,0.0001265867,0.0001048904,0.002589728],"category_scores_gemma":[0.00001513036,0.0002475557,0.00006068601,0.0004509544,0.0003318878,0.0001353779,0.00009493509,0.0003113444,5.922499e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001557037,"about_ca_system_score_gemma":0.0003563275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002073759,"about_ca_topic_score_gemma":0.004014094,"domain_scores_codex":[0.9980018,0.0001400528,0.0005394691,0.0005978297,0.0002359033,0.0004849366],"domain_scores_gemma":[0.9990663,0.0001275784,0.0002385883,0.0001989334,0.0001653733,0.0002032084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4878405,0.01644027,0.4452676,0.0003382232,0.002147856,0.0002009901,0.02061343,7.990021e-7,0.002076402,0.000004564629,0.001316623,0.02375283],"study_design_scores_gemma":[0.5728618,0.06710748,0.3516672,0.00008907911,0.001369557,0.0000173276,0.001850064,0.00002606576,0.001877102,0.000008932967,0.002729159,0.0003962709],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919549,0.003961249,0.000006332035,0.0005223989,0.0003982556,0.002820073,0.00009002446,0.00002723131,0.0002195771],"genre_scores_gemma":[0.9948387,0.001907282,0.0001911342,0.001289575,0.0002567508,0.001041775,0.00001569607,0.00005384776,0.0004053101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09360036,"threshold_uncertainty_score":0.9999977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05717419124661998,"score_gpt":0.355581271116952,"score_spread":0.298407079870332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}